Kimiafaam Pharmaceutical Company has always built its strategic goals on producing high-quality products at reasonable prices. In this direction, the company considers its greatest achievement to be delivering premium products and providing extensive services to its customers.
Kimiafaam is one of the active and leading companies in the field of veterinary medicines, various disinfectants, and cosmetic and hygiene products, having begun its operations in 1993 (1372 in the Iranian calendar).
Alongside offering high-quality and competitively priced therapeutic products for livestock, poultry, aquaculture, disinfectants, and cosmetic-hygiene items, the company provides extensive educational and informational services to its customers.
Kimiafaam has consistently aimed to make quality the foundation of its work in developing and offering a diverse range of products. Over the years, by relying on experienced consultants and specialists and the latest scientific research, the company has focused on delivering products that fully meet industry needs.
The primary activities of this group include acquiring new technologies in the pharmaceutical industry and related sectors, localizing these technologies, and identifying effective approaches to address existing challenges within domestic industries. To achieve this, the group maintains close collaboration with universities, laboratories, and reputable scientific institutions.
The R&D team continuously researches and analyzes up-to-date global findings. Alongside information obtained from academic and scientific centers, and through consultation with distinguished university professors, the team evaluates industry needs and challenges and processes this information accordingly.
To better fulfill its objectives, KimiaFam Pharmaceutical Group has not only upgraded and expanded its laboratory equipment within the Quality Control Laboratory at the factory but has also established a specialized laboratory for research and formulation. With significant investment in this area, the company has created the capacity to fully support all ongoing research activities.
The main activities of this group include acquiring new technologies in the pharmaceutical industry and related sectors, localizing these technologies, and identifying effective approaches to resolve existing challenges within domestic industries. To accomplish this, the group maintains close collaboration with universities, laboratories, and reputable scientific institutions.
The R&D department continually searches for and evaluates the latest global findings. Alongside information obtained from academic and scientific centers, and through consultation with distinguished university professors, the team analyzes industry needs and challenges and processes this information accordingly.
To better achieve its goals, KimiaFam Pharmaceutical Group has not only expanded and upgraded the laboratory equipment within its Quality Control Laboratory at the factory but has also established a specialized research and formulation laboratory. Through significant investment in this area, the company has created full support capabilities for ongoing research activities.
Certifications & Recognitions
